AKT1 and acute myeloid leukemia: However, in AML cells even at pharmacologically relevant concentration of MK2206, we did not find any considerable reduction in Nrf2 levels, suggesting that unlike in solid tumors, Nrf2 regulation in AML is not mediated via PI3/Akt pathway.